Resveratrol can exert anti-pancreatic cancer effects by inhibiting NFκB activation (60), HIF-1α-induced hypoxia pathways (61), and reducing RYR2 (62) and VEGF-B (63) expression. The gene discussed is RYR2; the disease is familial pancreatic carcinoma.